BC Advantage Funds
North America, British Columbia, Canada, North Vancouver
Description
BC Advantage Funds invests in early-stage life science, technology, and clean tech companies.
Investor Profile
BC Advantage Funds has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 17% of its total and boasts 7 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in Canada, United Kingdom.
- Strong thematic focus on Biotechnology, Internet, Telecommunications.
Stage Focus
- Series B (50%)
- Series C (17%)
- Series A (17%)
- Series Unknown (17%)
Country Focus
- Canada (67%)
- United Kingdom (33%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Internet
- Telecommunications
- Web Hosting
- Health Care
- Medical
- Pharmaceutical
- Therapeutics
- Manufacturing
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
